NEUREGENIX LIMITED

Dissolved Droitwich

Research and experimental development on biotechnology

1 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
N

NEUREGENIX LIMITED

Research and experimental development on biotechnology

Founded 14 Jan 2005 Dissolved Droitwich, United Kingdom 1 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

GORDONS80 LIMITED 14 Jan 2005 — 11 Apr 2005
Accounts Submitted 16 Sept 2024
Confirmation Submitted 23 Feb 2024 Next due 28 Jan 2025 16 months overdue
Net assets £-3K £3K 2023 year on year
Total assets £3K £51K 2023 year on year
Total Liabilities £5K £48K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Oakley Kidderminster Road Droitwich Worcestershire WR9 9AY United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NEUREGENIX LIMITED (05332791), a dissolved life sciences and medical technology company based in Droitwich, United Kingdom. Incorporated 14 Jan 2005. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£2.61k

Increased by £1.67k (+177%)

Net Assets

-£2.62k

Decreased by £2.61k (-52260%)

Total Liabilities

£5.35k

Decreased by £48.40k (-90%)

Turnover

N/A

Employees

1

Debt Ratio

196%

Increased by 96 (+96%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Ann LoganDirectorBritishEngland7217 May 2005Active

Shareholders

Shareholders (4)

University Of Birmingham
40.7%
Catherine Berry
27.9%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Ann Logan

British

Active
Notified 6 Apr 2016
Residence England
DOB July 1953
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Jan 2025GazetteGazette Dissolved Voluntary
22 Oct 2024GazetteGazette Notice Voluntary
9 Oct 2024DissolutionDissolution Application Strike Off Company
16 Sept 2024AccountsAnnual accounts made up to 31 Mar 2024
23 Feb 2024Confirmation StatementConfirmation statement made on 14 Jan 2024 with no updates
7 Jan 2025 Gazette

Gazette Dissolved Voluntary

22 Oct 2024 Gazette

Gazette Notice Voluntary

9 Oct 2024 Dissolution

Dissolution Application Strike Off Company

16 Sept 2024 Accounts

Annual accounts made up to 31 Mar 2024

23 Feb 2024 Confirmation Statement

Confirmation statement made on 14 Jan 2024 with no updates

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 years ago on 7 Jan 2025

Gazette Notice Voluntary

1 years ago on 22 Oct 2024

Dissolution Application Strike Off Company

1 years ago on 9 Oct 2024

Annual accounts made up to 31 Mar 2024

1 years ago on 16 Sept 2024

Confirmation statement made on 14 Jan 2024 with no updates

2 years ago on 23 Feb 2024